Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
Add more filters










Publication year range
1.
Pharmacol Biochem Behav ; 65(4): 577-83, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10764909

ABSTRACT

The present investigation introduces ricinine-elicited seizures as a novel chemical model of convulsive seizure. Ricinine, a neutral alkaloid obtained from the plant Ricinus communis, induces seizures when administered to mice at doses higher than 20 mg/kg. Animals presenting seizures showed a marked preconvulsive phase followed by short duration hind limb myoclonus, respiratory spasms, and death. The lethal nature of ricinine seizures is also pointed out as a good model to study the events causing death in clonic seizures, particularly those related to respiratory spasms, which are also observed in some types of human epilepsy. The behavioral signs of ricinine-elicited seizures are accompanied by electrographic alterations more evident during the preconvulsive phase in the cerebral cortex and more intense during the ictal phase both in the cortex and in the hippocampus. The ricinine-elicited seizures may be inhibited by diazepam but not by phenobarbital, phenytoin, or ethosuximide. Micromolar concentrations of ricinine cause a small decrease in the binding of [3H]-flunitrazepam to cerebral cortex membranes, but do not alter the binding of other radioligands to AMPA, 5-HT(1A), muscarinic, and alpha(1)-adrenergic receptors. Although ricinine presents a cyanide radical, only higher doses of ricinine (4 mM) caused a small impairment of mitochondrial respiration. These results suggest that the mechanism of action of ricinine probably involves the benzodiazepine site in the GABA(A) receptor. This may represent a new mechanism of drug-elicited seizures that may contribute to a better understanding of epilepsy and to new therapeutic approaches to this disease.


Subject(s)
Alkaloids/pharmacology , Antithyroid Agents/pharmacology , Convulsants/pharmacology , Pyridones , Seizures/chemically induced , Alkaloids/antagonists & inhibitors , Animals , Anticonvulsants/pharmacology , Behavior, Animal/drug effects , Brain Chemistry/drug effects , Convulsants/antagonists & inhibitors , Dose-Response Relationship, Drug , Electroencephalography/drug effects , Electrophysiology , Male , Mice , Mitochondria/drug effects , Mitochondria/metabolism , Oxygen Consumption/drug effects , Radioligand Assay , Receptors, Neurotransmitter/drug effects , Seizures/psychology
2.
Pharmacol Biochem Behav ; 65(2): 313-20, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10672984

ABSTRACT

6-Chloro-3'-nitroflavone integrates a list of nearly 70 flavone derivatives synthesized in our laboratories. The effects of 6-chloro-3'-nitroflavone on the benzodiazepine binding sites (BDZ-BSs) of the GABA(A) receptor were examined in vitro and in vivo. 6-Chloro-3'-nitroflavone inhibited the [3H]flunitrazepam ([3H]FNZ) binding to rat cerebral cortex membranes with a Ki of 6.68 nM and the addition of GABA to extensively washed membranes did not modify its affinity for the BDZ-BSs (GABA-shift = 1.16+/-0.12). The binding assays performed in rat striatal and cerebellar brain membranes showed that this compound has similar affinity to different populations of BDZ-BSs. Electrophysiological experiments revealed that 6-chloro-3'-nitroflavone did not affect GABA(A)-receptors (GABA(A)-Rs) responses recorded in Xenopus oocytes expressing alpha1beta2gamma2s subunits, but blocked the potentiation exerted by diazepam (DZ) on GABA-activated chloride currents. In vivo experiments showed that 6-chloro-3'-nitroflavone did not possess anxiolytic, anticonvulsant, sedative, myorelaxant actions in mice or amnestic effects in rats; however, 6-chloro-3'-nitroflavone antagonized diazepam-induced antianxiety action, anticonvulsion, short-term, and long-term amnesia and motor incoordination. These biochemical, electrophysiological, and pharmacological results suggest that 6-chloro-3'-nitroflavone behaves as an antagonist of the BDZ-BSs.


Subject(s)
Diazepam/pharmacology , Flavonoids/pharmacology , Flunitrazepam/metabolism , GABA Modulators/pharmacology , Learning/drug effects , Motor Activity/drug effects , Receptors, GABA-A/drug effects , Animals , Anticonvulsants , Diazepam/therapeutic use , GABA-A Receptor Antagonists , Male , Mice , Rats , Rats, Wistar , Seizures/drug therapy , Xenopus
3.
Biochem Biophys Res Commun ; 262(3): 643-6, 1999 Sep 07.
Article in English | MEDLINE | ID: mdl-10471378

ABSTRACT

6-Methyl-3'-bromoflavone inhibited [(3)H]flunitrazepam binding to the benzodiazepine binding site of the GABA(A) receptor (BDZ-bs) with Ki values between 10 and 50 nM in different brain regions. The GABA ratio of 1.03 for [(3)H]flunitrazepam binding to cerebral cortex, 0.76 for cerebellum, 0.7 for hippocampus, 0.7 for striatum, and 0.8 for spinal cord indicated an antagonistic or weak inverse agonistic profile of 6-methyl-3'-bromoflavone on BDZ-bs. Unlike classical benzodiazepines, it had no anticonvulsant, anxiolytic, myorelaxant, sedative, amnestic or motor incoordination effects. However, it antagonized the muscle relaxant, the sedative effect, and the changes in locomotor activity induced by diazepam. Taken together, these findings suggest that 6-methyl-3'-bromoflavone has an antagonistic profile on the BDZ-bs.


Subject(s)
Brain/metabolism , Flavonoids/pharmacology , GABA Antagonists/pharmacology , Receptors, GABA-A/metabolism , Spinal Cord/metabolism , Synaptosomes/metabolism , Animals , Binding Sites , Binding, Competitive , Cerebellum/metabolism , Cerebral Cortex/metabolism , Corpus Striatum/metabolism , Flavonoids/chemical synthesis , Flavonoids/chemistry , Flunitrazepam/pharmacokinetics , GABA-A Receptor Antagonists , Hippocampus/metabolism , Intracellular Membranes/metabolism , Kinetics , Ligands , Male , Mice
4.
Neurobiol Learn Mem ; 72(2): 78-94, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10438649

ABSTRACT

Rats selected as "anxious", "nonanxious," or normal according to their behavior in an elevated plus maze were submitted to memory tasks and the densities of central benzodiazepine receptors in the amygdala and the hippocampus were studied. Anxious rats exibited better retention scores in the inhibitory avoidance task while nonanxious rats exibited worse retention scores in inhibitory and two-way active avoidance tasks compared to normal rats. No significant differences were detected in the retention scores for habituation to an open field. Nonanxious rats presented a lower benzodiazepine receptor density in the hippocampus but not in the amygdala compared to the other groups. These data suggest that the benzodiazepine receptors are involved in the effect of "anxiety" or emotional states on memory storage processes.


Subject(s)
Anxiety/genetics , Arousal/genetics , Habituation, Psychophysiologic/genetics , Mental Recall/physiology , Selection, Genetic , Amygdala/physiology , Animals , Brain Mapping , Gene Expression/physiology , Habituation, Psychophysiologic/physiology , Hippocampus/physiology , Humans , Male , Maze Learning/physiology , Models, Genetic , Rats , Rats, Wistar , Receptors, GABA-A/genetics , Receptors, GABA-A/physiology , Retention, Psychology/physiology
5.
J Pharm Pharmacol ; 51(5): 519-26, 1999 May.
Article in English | MEDLINE | ID: mdl-10411210

ABSTRACT

The list of activities of plant flavonoids did not include effects on the central nervous system (CNS) up to 1990, when our laboratory described the existence of natural anxiolytic flavonoids. The first of these was chrysin (5,7-dihydroxyflavone), followed by apigenin (5,7,4'-trihydroxyflavone) and flavone itself. Semisynthetic derivatives of flavone obtained by introducing halogens, nitro groups or both in its molecule, give rise to high affinity ligands for the benzodiazepine receptor, active in-vivo; 6,3'-dinitroflavone, for example, is an anxiolytic drug 30 times more potent than diazepam. The data collected in this paper make clear that some natural flavonoids are CNS-active molecules and that the chemical modification of the flavone nucleus dramatically increases their anxiolytic potency.


Subject(s)
Anti-Anxiety Agents/pharmacology , Central Nervous System/drug effects , Flavonoids/pharmacology , Anti-Anxiety Agents/chemistry , Chamomile , Flavonoids/chemistry , Humans , Oils, Volatile/chemistry , Oils, Volatile/pharmacology , Plants, Medicinal
6.
Behav Pharmacol ; 10(1): 99-104, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10780306

ABSTRACT

Rats were implanted bilaterally with cannulae in the CA1 region of the dorsal hippocampus. After recovery from surgery, they were submitted to a water-finding task, which required detecting a water tube in an open field, and then remembering its location under conditions of thirst. This task was acquired simultaneously with habituation to the open field. Training and test sessions lasted 2 min, in addition to the time spent at the water tube. The training-test interval was 24 h, during which the animals were deprived of water. Immediate post-training intra-hippocampal administration of the calcium/calmodulin-dependent protein kinase II (CaMKII) inhibitor KN-62 (3.6 ng/side) attenuated memory of the water-finding task, but not that of the habituation acquired concomitantly. However, when the habituation was carried out alone in the absence of the water-finding task, its retention was inhibited by KN-62. Thus, depending on circumstances, habituation can be memorized with or without hippocampal CaMKII activity. In the post-training period, CA1 neurones appear to 'choose' which task will be processed by a metabolic pathway that includes CaMKII.


Subject(s)
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives , Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors , Enzyme Inhibitors/pharmacology , Habituation, Psychophysiologic/drug effects , Hippocampus/physiology , Maze Learning/drug effects , Memory/drug effects , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/administration & dosage , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/pharmacology , Animals , Enzyme Inhibitors/administration & dosage , Male , Microinjections , Rats , Rats, Wistar
7.
Pharmacol Biochem Behav ; 61(3): 239-46, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9768558

ABSTRACT

6-Bromo-3'-nitroflavone is a synthetic flavone derivative that selectively recognizes benzodiazepine receptors and has potent anxiolytic-like effects. Here, we describe in detail its pharmacological characterization. When i.p. injected in mice, 6-bromo-3'-nitroflavone (0.01-0.3 mg/kg) had an anxiolytic-like effect in the elevated plus-maze test. This effect was blocked by the specific benzodiazepine receptor antagonist, flumazenil. In addition, it exhibited anxiolytic-like actions when given orally (1 mg/kg). 6-Bromo-3'-nitroflavone did not exhibit myorelaxant effects (up to 30 mg/kg, i.p.). Unlike diazepam, this flavonoid produced no anterograde amnesia in a one-trial inhibitory avoidance learning. On the other hand, 6-bromo-3'-nitroflavone possessed mild anticonvulsant activity (0.1 mg/kg, i.p.) and provoked sedative-depressant actions only at doses 100-1000 times higher than those producing anxiolytic-like effects. 6-Bromo-3'-nitroflavone (0.1-1 mM) produced a lower potentiation of gamma-amino-butyric acid (GABA)-stimulated 36Cl- influx (126-138%) in comparison to diazepam (0.1 mM: 166%) in cerebral cortical membrane vesicles. Taken together, these findings suggest that 6-bromo-3'-nitroflavone has anxiolytic-like action possibly behaving as a partial agonist of the benzodiazepine receptors.


Subject(s)
Anti-Anxiety Agents/pharmacology , Flavonoids/pharmacology , GABA-A Receptor Agonists , Animals , Avoidance Learning/drug effects , Avoidance Learning/physiology , Flavonoids/therapeutic use , Male , Maze Learning/drug effects , Maze Learning/physiology , Mice , Motor Activity/drug effects , Motor Activity/physiology , Pentobarbital/pharmacology , Pentylenetetrazole/pharmacology , Psychomotor Performance/drug effects , Seizures/chemically induced , Seizures/drug therapy , Sleep/drug effects , Sleep/physiology
8.
Biochem Biophys Res Commun ; 249(2): 481-5, 1998 Aug 19.
Article in English | MEDLINE | ID: mdl-9712722

ABSTRACT

Solution phase combinatorial synthesis of flavone derivatives and evaluation of their affinity for the central benzodiazepine receptors is described. The libraries preparation is simple and provides a convenient method for rapid compound generation and screening. Thirty one new compounds were obtained of which the most promising, as high affinity benzodiazepine receptor ligands, were 6-bromo-3'-fluoroflavone; 6,3'-dichloroflavone; 6-bromo-3'-chloroflavone and 6-chloro-3'-bromoflavone.


Subject(s)
Flavonoids/chemical synthesis , Flavonoids/metabolism , Receptors, GABA-A/metabolism , Animals , Binding, Competitive , Cell Membrane/metabolism , Cerebellum/metabolism , Cerebral Cortex/metabolism , Chromatography, High Pressure Liquid , Flavonoids/chemistry , Flunitrazepam/metabolism , Mice , Molecular Structure , Rats , Solutions , gamma-Aminobutyric Acid/metabolism
9.
Phytomedicine ; 5(3): 235-43, 1998 May.
Article in English | MEDLINE | ID: mdl-23195847

ABSTRACT

Flavonoids isolated from plants used as tranquilizers in folkloric medicine have a selective affinity, for central benzodiazepine receptors (BDZ-Rs) and some of them possess a pharmacological profile compatible with a partial agonist action. Synthetic derivatives of the common flavone nucleus, give rise to high affinity ligands when electronegative groups are introduced in carbons 6 and/or 3'. Representative compounds such as 6,3'-dinitroflavone and, 6-bromo-3'-nitroflavone exhibit a high affinity for the BDZ-Rs (Ki = 1.5 to 30 nM) and have anxiolytic effects not associated with myorelaxant, sedative or amnesic actions. These compounds or similar ones, could lead to improved therapeutic drugs in the treatment of anxiety.

10.
Neurochem Res ; 22(4): 419-25, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9130252

ABSTRACT

Benzodiazepines (BDZs) are the most widely prescribed class of psychoactive drugs in current therapeutic use, despite the important unwanted side-effects that they produce such as sedation, myorelaxation, ataxia, amnesia, ethanol and barbiturate potentiation and tolerance. Searching for safer BDZ-receptor (BDZ-R) ligands we have recently demonstrated the existence of a new family of ligands which have a flavonoid structure. First isolated from plants used as tranquilizers in folkloric medicine, some natural flavonoids have shown to possess a selective and relatively mild affinity for BDZ-Rs and a pharmacological profile compatible with a partial agonistic action. In a logical extension of this discovery various synthetic derivatives of those compounds, such as 6,3'-dinitroflavone were found to have a very potent anxiolytic effect not associated with myorelaxant, amnestic or sedative actions. This dinitro compound, in particular, exhibits a high affinity for the BDZ-Rs (Ki = 12-30 nM). Due to their selective pharmacological profile and low intrinsic efficacy at the BDZ-Rs, flavonoid derivatives, such as those described, could represent an improved therapeutic tool in the treatment of anxiety. In addition, several flavone derivatives may provide important leads for the development of potent and selective BDZ-Rs ligands.


Subject(s)
Flavonoids/metabolism , Receptors, GABA-A/metabolism , Animals , Flavonoids/chemistry , Flavonoids/pharmacology , Ligands , Molecular Structure
11.
Phytomedicine ; 4(1): 47-52, 1997 Mar.
Article in English | MEDLINE | ID: mdl-23195245

ABSTRACT

Salvia guaranitica St. Hil. is a traditional medicinal plant used in Latin America as sedative. We have recently demonstrated the presence of cirsiliol in its extracts and found that this flavonoid is a competitive low affinity benzodiazepine receptor ligand (Marder et al., 1996). This report describes the pharmacological properties of Salvia guaranitica extracts and of its active principle, cirsiliol. A partially purified fraction of this plant, administered intraperitoneally in mice (in a dose equivalent to 3 g of the fresh plant), exhibited sedative and hypnotic effects as measured in the hole board and in the pentobarbital-induced sleep tests, respectively. On the other hand, this fraction had no anxiolytic or myorelaxant effects. In the pentobarbital-induced sleep test, cirsiliol (2-10mg/kg, i. p.) exhibited a dose-dependent hypnotic action. In contrast, it did not produce myorelaxant (up to 30mg/kg) or anticonvulsant (up to 10mg/kg) effects. Cirsiliol was found to be more potent in displacing (3)H Zolpidem binding (K(i) = 20 LiM) than (3)H flunitrazepam binding (K(i) = 200 µM) to benzodiazepine receptors from rat cerebral cortex. It is concluded that Salvia guaranitica extracts and its active principle cirsiliol, possess sedative and hypnotic properties; cirsiliol produces these effects probably acting on the so-called type I benzodiazepine receptor.

12.
Eur J Pharmacol ; 318(1): 23-30, 1996 Dec 27.
Article in English | MEDLINE | ID: mdl-9007508

ABSTRACT

6,3'-Dintroflavone is a synthetic flavone derivative with high affinity for central benzodiazepine receptors that has anxiolytic effects. Here, we describe its biochemical and pharmacological characterization. 6,3'-Dinitroflavone inhibited differentially [3H]flunitrazepam binding to central benzodiazepine receptors in several brain regions, showing a lower Ki value in the cerebellum (central benzodiazepine receptor type I-enriched area), and a higher Ki value in the spinal cord and in the dentate gyrus (central benzodiazepine receptor type II-enriched area). When i.p. injected in mice, 6,3'-dinitroflavone had a potent anxiolytic effect in the elevated plus maze test. This effect was blocked by the specific central benzodiazepine receptor antagonist, Ro 15-1788. 6,3'-Dinitroflavone did not exhibit anticonvulsant or myorelaxant effects in mice or amnestic effects in rats. Moreover, it abolished the myorelaxant effect of diazepam. On the other hand, 6,3'-dinitroflavone possessed a mild sedative action only at doses 100-300-fold greater than the anxiolytic one. Based on these findings, we suggest that 6,3'-dinitroflavone has a benzodiazepine partial agonist profile, with low selectivity for central benzodiazepine receptor types I and II.


Subject(s)
Anti-Anxiety Agents/pharmacology , Behavior, Animal/drug effects , Central Nervous System/drug effects , Flavonoids/pharmacology , Receptors, GABA-A/drug effects , Animals , Autoradiography , Brain/drug effects , Brain/metabolism , Central Nervous System/metabolism , Flunitrazepam/pharmacology , Ligands , Male , Mice , Rats , Rats, Wistar , Spinal Cord/drug effects , Spinal Cord/metabolism
14.
Phytomedicine ; 3(1): 29-31, 1996 May.
Article in English | MEDLINE | ID: mdl-23194857

ABSTRACT

Ligands for the central benzodiazepine receptors have been detected in the crude ethanolic extract of Salvia guaranitica. The compounds responsible for the activity were isolated by bioassay-directed fractionation and have been characterised as cirsiliol (5, 3', 4'-trihydroxy 6,7-dimethoxyflavone) and caffeic acid ethyl ester.

15.
Psychopharmacology (Berl) ; 122(1): 51-7, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8711064

ABSTRACT

Utilizing psychogenetically selected Roman high- and low-avoidance rats (RHA/Verh and RLA/Verh), the present experiments investigated the effects of prenatally administered vehicle and diazepam (1 and 3 mg/kg per day, SC) on the behavior and neurochemistry of adult, male offspring. Active, two-way avoidance behavior was analyzed in 96 rats, at 6 months of age, and swimming navigation in 68 others, at 11 months. Three weeks after testing, selected brain areas from the latter animals were immunoassayed for benzodiazepine (BZD)-like molecules. The 3 mg/kg dose of diazepam both decreased freezing behavior in the shuttle box and reduced the hippocampal content of BZD-like molecules in the RLA/Verh male rats. Swimming navigation (spatial learning), at which the RLA/Verh rats were more adept, was not specifically affected by prenatal diazepam in either rat line. The possibility exists that an increased hippocampal release of BZD-like substances may be necessary to alter shuttle box behavior in RLA/Verh rats.


Subject(s)
Avoidance Learning/drug effects , Diazepam/pharmacology , Maze Learning/drug effects , Prenatal Exposure Delayed Effects , Animals , Brain Chemistry/drug effects , Female , Genetics, Behavioral/drug effects , Locomotion , Male , Pregnancy , Rats
16.
Neurobiol Learn Mem ; 64(3): 257-64, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8564379

ABSTRACT

The AMPA receptor has been shown to participate in the synaptic mechanisms involved in certain forms of learning and memory. We have previously demonstrated that the posttraining infusion of 6-cyano-7-nitroquinoxaline-2,3-dione, an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor blocker, into the dorsal hippocampus of rats, causes retrograde amnesia of an inhibitory avoidance training. Here, we report on the effect of this learning task on 3[H]AMPA binding to frozen rat brain sections. By using a quantitative autoradiographic analysis, we were able to demonstrate that the binding of 3[H]-AMPA was increased by 40-80% in the CA1, CA2, CA3, and dentate gyrus subregions of the hippocampal formation of rats trained in a step-down inhibitory avoidance paradigm, compared to naive, shocked, and free exploration controls. This effect was evident between 30 and 180 min after training, and it was mainly due to an increase in the density, but not in the affinity of binding sites. No alterations in 3[H]AMPA binding were observed either in those animals that received only the footshock (shocked group) or in animals that were submitted to 1 min of free exploration of the training box (free exploration group). In the rest of the brain regions, including the frontal cortex, entorhinal cortex, striatum, amygdala, cerebellum, and thalamus, the 3[H]AMPA binding remained unchanged. In addition, the binding of 3[H]muscimol and 3[H]-flunitrazepam to the GABAA/benzodiazepine receptor complex was unaltered in all the experimental groups. In conclusion, rats submitted to a one-trial inhibitory avoidance training showed a rapid, selective, and specific increase in 3[H]AMPA binding in the hippocampal formation. The present findings support the hypothesis that hippocampal AMPA receptors are involved in the neural mechanisms underlying certain forms of learning and memory.


Subject(s)
Avoidance Learning/physiology , Hippocampus/physiology , Mental Recall/physiology , Neural Inhibition/physiology , Receptors, AMPA/physiology , Animals , Brain Mapping , Dentate Gyrus/physiology , Long-Term Potentiation/physiology , Male , Rats , Rats, Wistar , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/pharmacokinetics
17.
Planta Med ; 61(3): 213-6, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7617761

ABSTRACT

The dried flower heads of Matricaria recutita L. (Asteraceae) are used in folk medicine to prepare a spasmolytic and sedative tea. Our fractionation of the aqueous extract of this plant led to the detection of several fractions with significant affinity for the central benzodiazepine receptor and to the isolation and identification of 5,7,4'-trihydroxyflavone (apigenin) in one of them. Apigenin competitively inhibited the binding of flunitrazepam with a Ki of 4 microM and had no effect on muscarinic receptors, alpha 1-adrenoceptors, and on the binding of muscimol to GABAA receptors. Apigenin had a clear anxiolytic activity in mice in the elevated plusmaze without evidencing sedation or muscle relaxant effects at doses similar to those used for classical benzodiazepines and no anticonvulsant action was detected. However, a 10-fold increase in dosage produced a mild sedative effect since a 26% reduction in ambulatory locomotor activity and a 35% decrement in hole-board parameters were evident. The results reported in this paper demonstrate that apigenin is a ligand for the central benzodiazepine receptors exerting anxiolytic and slight sedative effects but not being anticonvulsant or myorelaxant.


Subject(s)
Cerebral Cortex/metabolism , Flavonoids/metabolism , Flavonoids/pharmacology , Learning/drug effects , Motor Activity/drug effects , Oils, Volatile/metabolism , Oils, Volatile/pharmacology , Plants, Medicinal , Receptors, GABA-A/metabolism , Animals , Cattle , Cell Membrane/metabolism , Chamomile , Flavonoids/isolation & purification , Flunitrazepam/metabolism , Ligands , Maze Learning/drug effects , Medicine, Traditional , Mice , Oils, Volatile/isolation & purification , Phytotherapy , Synaptosomes/metabolism
18.
Neurochem Int ; 25(4): 395-400, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7820072

ABSTRACT

The long-term effects of the systemic administration of DSP4 (N-(2-chloroethyl)N-ethyl-2-bromobenzylamine hydrochloride), a selective noradrenergic neurotoxin, on the endogenous levels of monoamines and their metabolites and on alpha- and beta-adrenoceptors in selected brain regions of the rat were examined. After 7 days, DSP4 caused a marked reduction (about 80%) of endogenous noradrenaline levels in locus coeruleus-innervated regions. At 90, 240 and 300 days after DSP4 injection, a partial and gradual recovery (50%, 41% and 25% of control values, respectively) of the noradrenaline cortical levels was evident. One year after DSP4 administration, brain regional noradrenaline stores were almost completely recovered. No changes in 5-hydroxytryptamine levels were observed in the three time intervals, but a mild decrease in cortical and hippocampal 5-hydroxyindolacetic acid levels was found 7 days after DSP4 injection. Following the profound noradrenaline depletion seen at 7 days, the cerebral cortical density of alpha 1-, alpha 2- and beta-adrenoceptors was significantly increased. Assessment of adrenergic receptors in cerebral cortex at 365 days after DSP4 injection, indicated that alpha 1- and alpha 2-adrenoceptor densities did not differ from control values; however, the density of beta-adrenoceptors remained increased. No changes were observed in the affinities of the three types of adrenoceptors studied. These results indicate that after a selective noradrenergic denervation induced by DSP4, there is a slow and gradual recovery of noradrenaline stores and of alpha 1- and alpha 2-adrenoceptor populations, suggesting a possible regrowth and/or collateral sprouting of noradrenergic terminals.


Subject(s)
Benzylamines/pharmacology , Brain/drug effects , Neurons/drug effects , Neurotransmitter Uptake Inhibitors/pharmacology , Norepinephrine/metabolism , Animals , Benzylamines/administration & dosage , Biogenic Monoamines/metabolism , Brain/metabolism , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Female , Kinetics , Male , Neurons/metabolism , Neurotoxins/pharmacology , Rats , Rats, Wistar , Receptors, Adrenergic, alpha/metabolism , Receptors, Adrenergic, beta/metabolism
19.
J Ethnopharmacol ; 44(1): 47-53, 1994 Aug.
Article in English | MEDLINE | ID: mdl-7990504

ABSTRACT

Tilia species are traditional medicinal plants widely used in Latin America as sedatives and tranquilizers. For this purpose, the infusion of their inflorescences is used to prepare a tea. In this study extracts of inflorescences from Tilia tomentosa Moench, one of the species found in the market, were purified using a benzodiazepine (BZD) binding assay to detect BZD receptor ligands in the different fractions. One of the ligands was identified as kaempferol, but it had low affinity (Ki = 93 microM) for this receptor, and did not produce sedative or anxiolytic effects in mice. On the other hand, a complex fraction, containing as yet unidentified constituents, but probably of a flavonoid nature, when administered intraperitoneally in mice, had a clear anxiolytic effect in both the elevated plus-maze and holeboard tests, two well validated pharmacological tests to measure anxiolytic and sedative compounds. This active fraction had no effect on total and ambulatory locomotor activity. In conclusion, our results demonstrate the occurrence of active principle(s) in, at least, one species of Tilia that may explain its ethnopharmacological use as an anxiolytic.


Subject(s)
Anti-Anxiety Agents/isolation & purification , Flavonoids , Kaempferols , Plant Extracts/isolation & purification , Plants, Medicinal/chemistry , Receptors, GABA-A/metabolism , Animals , Anti-Anxiety Agents/metabolism , Anti-Anxiety Agents/pharmacology , Chromatography, High Pressure Liquid , Injections, Intraperitoneal , Ligands , Male , Mice , Plant Extracts/metabolism , Plant Extracts/pharmacology , Psychomotor Performance/drug effects , Quercetin/analogs & derivatives , Quercetin/isolation & purification , Quercetin/metabolism , Quercetin/pharmacology
20.
Behav Neural Biol ; 61(3): 203-5, 1994 May.
Article in English | MEDLINE | ID: mdl-8067974

ABSTRACT

We investigated the effect of a bilateral post-training intracerebral infusion of KN62, a specific inhibitor of calcium/calmodulin-dependent protein kinase II (CaM-II), on memory. This enzyme plays a crucial role in the early phases of long-term potentiation. Male Wistar rats were implanted bilaterally with cannulae aimed at the CA1 region of the dorsal hippocampus or at the junction between the central and the basolateral nuclei of the amygdala. After recovery, rats were trained in step-down inhibitory avoidance using a 0.5-mA footshock and tested for retention 24 h later. At various times after training (0, 30, 120, or 240 min for the animals implanted into the hippocampus; 0 or 240 min for the animals implanted in the amygdala) they received, through the cannulae, an infusion of vehicle (0.1% dimethylsulfoxide in water) or KN62 (100 mumol/side). KN62 caused full retrograde amnesia when given 0 min after training into either the amygdala or the hippocampus. When given into the hippocampus 30 min post-training it had a partial amnestic effect. When given 120 min after training into the hippocampus, or 240 min after training into either structure, KN62 had no effect. The data suggest that the early phase of memory requires intact CaM-II activity in the amygdala and hippocampus and support the hypothesis that memory involves long-term potentiation initiated at the time of training in both structures.


Subject(s)
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives , Amnesia, Retrograde/chemically induced , Amygdala/drug effects , Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors , Hippocampus/drug effects , Isoquinolines/adverse effects , Isoquinolines/pharmacology , Piperazines/adverse effects , Piperazines/pharmacology , Animals , Avoidance Learning/drug effects , Behavior, Animal/drug effects , Male , Rats , Rats, Wistar , Retention, Psychology/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...